Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Hyperplasia × Urination × Genitourinary × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Acute Kidney Injury 2 Urinary Bladder Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Renal Insufficiency 1 Prostatic Hyperplasia 1 Neoplasms 1 Kidney Neoplasms 1 Disease 1

Interventions

Dutasteride 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Transurethral Resection of Prostate 2 Radiotherapy 2 Prostatectomy 2 Blood Specimen Collection 2 proxalutamide 1 mirabegron 1 Urination 1 TroVax 1 Transurethral Resection of Bladder 1 Therapeutics 1 Tamsulosin 1 Standard of Care 1 Risedronic Acid 1 Psychiatric Rehabilitation 1 Prostate-Specific Antigen 1 Papaverine 1 Needles 1 Microspheres 1 Magnetic Resonance Spectroscopy 1 Lycopene 1 Levofloxacin 1 Finasteride 1 Electroacupuncture 1 Doxazosin 1 Docetaxel 1 Diclofenac 1 Dexmedetomidine 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116851 2023-11-03

PROMIC

Turku University Hospital

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡